Navigation Links
Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants

rned to damaged tissue, leading to an inflammatory response that could result in poor organ function. In the United States, approximately 28,000 patients received a solid organ transplant in 2007.

Orphan drug designation provides an accelerated FDA review process, tax advantages and a seven-year period of market exclusivity in the US upon product approval.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceutical and biological products and drug/device combinations for the critically ill in the hospital and ICU setting. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to the ongoing clinical development as well as the marketing and selling of its INOmax product, Ikaria is engaged in a number of Phase 2 trials with Covox(R) (carbon monoxide) for inhalation and Phase 1 trials with hydrogen sulfide (H2S) for various critical care indications. Ikaria has a staff of approximately 400 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit

CONTACTS: Matthew Bennett, Ikaria, (908) 238-6673,; or Jason Rando, The Ruth Group, 646-536-7025,

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Artificial Gravity receives 2008 Life Science Book Award
2. Colorado Sen. Ken Salazar receives Soil Stewardship Award
3. Childrens Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach
4. Engineer receives $1.5M grant for nanoparticle cancer research
5. UC Riverside bioengineer receives high honor from chemical engineers
6. Pitt receives $2.5 million to simulate and analyze brain, immune system activity
7. NJIT biomedical engineer receives NSF Career Development Award
8. Monash researcher receives prestigious Commonwealth Health Ministers award
9. Spradling receives Gruber Foundation Genetics Prize for new genetic techniques
10. UNH receives $380,000 grant to study organic dairy as closed ecosystem
11. Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater
Post Your Comments:
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
(Date:9/26/2015)... 26th, 2015  Results of a TactioRPM pilot ... today at the Stanford Medicine X Conference. In ... Dashboards, Connected Health Devices and Pharmacogenomics", Roger ... will explain how senior patients equipped with connected ... pharmacist via the TactioRPM remote patient monitoring platform ...
(Date:9/10/2015)... This report provides detailed descriptions of the sensor types ... types that will dominate in the future. Many product ... technology hype curve in the last five years before ... all of them is the prominence of sensor options ... Sensors collect data about the physical and chemical properties ...
Breaking Biology News(10 mins):Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 2Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 3Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 4Image Sensors Market Size to Reach $12.03 Billion By 2020: Grand View Research, Inc. 5Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference 2Results of TactioRPM Pilot in a Senior Home Unveiled at Stanford Med X Conference 3Wearable Sensors 2015-2025: Market Forecasts, Technologies, Players 2
... limited by the seasons, particularly in colder climates ... researchers and fruit breeders, newly developed varieties are ... produce fruit during the offseasonresulting in economic bonuses ... the new varieties of blackberry called "primocane-fruiting", which ...
... The roe of hake, lumpsucker and salmon is the best dietary ... researchers at the University of Almera (UAL). The scientists analysed the ... these contained high levels of these fatty acids, which are essential ... precise understanding of the nutritional potential of the roe of marine ...
... , SAN DIEGO, ... has converted part of an existing building (Keen Hall), including ... cell core facility for the University of California, Riverside. ... , "A key project element was to ensure that although ...
Cached Biology News:New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2Kornberg Associates | Architects Completes UC Riverside Stem Cell Core Facility Project 2
(Date:10/1/2015)... WORCESTER, Mass. and TORONTO ... ( ) (OTCQB: GNBT) today announced the issuance ... for medicinal purposes and the joint venture between Generex ... design and development of products for the delivery of ... the buccal mucosa (the inner lining of the mouth). ...
(Date:10/1/2015)... 2015  xG Health Solutions, a leading healthcare ... new platform for communication and collaboration with healthcare ... and health plans improve the quality and efficiency ... solutions, products and educational resources. ... clinicians, we know the process of re-engineering care ...
(Date:10/1/2015)... 1, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... in the upcoming Aegis Growth Conference, taking place October ...  Josh Hexter, COO of Oramed, will present a corporate ... Details:   2015 Aegis Growth Conference ...
(Date:10/1/2015)... (PRWEB) , ... October 01, 2015 , ... Mark Seymour, of Radiant Hearth in Potsdam, ... and built a Tulikivi masonry heater for the Mac Kentley family in northern New York. ... that the family's boiler did. One fire is normally enough to keep the home comfortable ...
Breaking Biology Technology:Generex Announces Issuance of Buccal Cannabis White Paper 2Generex Announces Issuance of Buccal Cannabis White Paper 3Generex Announces Issuance of Buccal Cannabis White Paper 4xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2Oramed to Present at the Aegis Capital Growth Conference 2Oramed to Present at the Aegis Capital Growth Conference 3The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2
... 15 Congressional Quarterly presents a 360-degree look at ... versions of biotech drugs. This CQ Forum will include ... and leading researchers regarding the complex structures of biologics ... the availability of these products save money for consumers? ...
... Pharmaceuticals, Inc. (Nasdaq: HEPH ), a leader in ... based on endogenous adrenal steroid hormones, today announced the board ... and CEO of Hollis-Eden Pharmaceuticals, Inc. Dr. Frincke was ... , Dr. Frincke joined Hollis-Eden as Vice President, Research and ...
... , HONOLULU, June 15 Nanopoint Inc., an ... products, today announced that effective immediately its cellTRAY ... to the European marketplace. Nanopoint,s cellTRAY Imaging and ... of applications including drug discovery, assisted reproductive technology ...
Cached Biology Technology:Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 2Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 3Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems 2